The Evaluation of Lung Function in Adults with Mild-to-Moderate Asthma Following Treatment with Ciclesonide 80 μg Twice Daily or 160 μg Once Daily.

被引：0

作者：

Meltzer, E. O. ^{[1
]}

LaForce, C. ^{[2
]}

Korenblat, P. ^{[3
]}

Karafilidis, J. ^{[4
]}

Andrews, W. ^{[4
]}

机构：

[1] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA

[2] Univ N Carolina, Sch Med, Raleigh, NC USA

[3] Clin Res Ctr, St Louis, MO USA

[4] Sepracor Inc, Marlborough, MA USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A2803

引用

页数：1

共 50 条

[1] Assessment of Lung Function in Adults with Uncontrolled Mild-to-Moderate Asthma Following Treatment with Ciclesonide 80 μg Twice Daily and 160 μg Once Daily.
Berger, W. E.
Bernstein, D. I.
Andrews, W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[2] Evaluating Pulmonary Function with Ciclesonide 80 μG Twice Daily or 160 μG Once Daily in the Morning in Patients with Mild-to-moderate Asthma Not Using an Inhaled Corticosteroid
Kerwin, E.
Andrews, W.
Pedinoff, A.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S262 - S262
[3] Comparison of the therapeutic efficacy between ciclesonide 80 μg and 160 μg once-daily in 40 children with mild-to-moderate asthma
Tsuzuki, Y.
Narita, M.
Oka, T.
Kajino, M.
Ooshima, M.
Hamada, I
ALLERGY, 2013, 68 : 26 - 26
[4] An Evaluation Of Asthma Control And Pulmonary Function Following Treatment With Ciclesonide 80 G Twice Daily In Subjects With Mild-To-Moderate Persistent Asthma Previously Receiving Fluticasone Propionate
Prenner, B. M.
Meltzer, E. O.
Desai, S. Y.
Wang, B.
Karafilidis, J.
Walsh, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[5] Ciclesonide 80 μG or 320 μG once daily achieves lung function improvement comparable with budesonide 200 μG twice daily in patients with persistent asthma
Hansel, T
Biberger, C
Engelstätter, R
THORAX, 2004, 59 (01) : 71 - 71
[6] Effects of hydrofluoroalkane formulations of ciclesonide 400 μg once daily vs fluticasone 250 μg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma
Lee, DKC
Haggart, K
Currie, GP
Bates, CE
Lipworth, BJ
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 26 - 33
[7] Comparison of ciclesonide 160μg once daily with fluticasone propionate 250μg twice daily in maintenance therapy of patients with stable asthma
Bladgen, M.
Rozen, D.
Vereecken, G.
Gruss, C.
Lawo, J.
Engelstaetter, R.
ALLERGY, 2007, 62 : 144 - 144
[8] Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma
Pearlman, DS
Berger, WE
Kerwin, E
LaForce, C
Kundu, S
Banerji, D
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (06) : 1206 - 1212
[9] Ciclesonide 160 μg once daily is as effective as budesonide 400 μg once daily in paediatric patients with persistant asthma
von Berg, A
Garcia, ML
Hellbardt, S
Bethke, TD
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S11 - S11
[10] Quality of life is improved by ciclesonide 160 μg once daily and budesonide 400 μg once daily in pediatric patients with persistent asthma
Verrneulen, JH
Latos, T
Müller, T
Engelstätter, R
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S184 - S184

← 1 2 3 4 5 →